Middletown, DE -- (SBWIRE) -- 09/05/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: MiMedx Group Inc (NASDAQ:MDXG), Hudson City Bancorp, Inc.(NASDAQ:HCBK), Exelixis, Inc.(NASDAQ:EXEL), Unilife Corp(NASDAQ:UNIS)
MiMedx Group Inc(NASDAQ:MDXG) gained volume of 4.85 million shares and the average volume of the stock remained 356,461.00shares. The 52 week range of the stock remained $1.81 - $7.73 and the day range was $1.81 - $6.21.The stock opened the session at $6.05, and closed the session at $3.85. The stock showed a negative performance of -36.49% in previous trading session. MiMedx Group, Inc., together with its subsidiaries, operates as an integrated developer, manufacturer, and marketer of patent protected regenerative biomaterial products and allografts processed from human amniotic membranes.
Has MDXG Found The Bottom and Ready To Move Up? Find Out Here
In previous session, Hudson City Bancorp, Inc. (NASDAQ:HCBK) traded 4.72 million shares and the average volume of the stock remained 3.16 million shares. The 52 week range of the stock remained $7.16 - $9.79. The stock was a bull and advanced +1.03%, while its closing price stayed at $9.34. The market capitalization of the stock remained 4.93 billion. The half-yearly trend of the stock remained positive +8.23%. Hudson City Bancorp, Inc. operates as the holding company of Hudson City Savings Bank that provides various banking products and services in the United States. Its deposit products include passbook and statement savings accounts, interest-bearing transaction accounts, as well as IRA accounts and qualified retirement plans.
For How Long HCBK will fight for Profitability? Read This Trend Analysis report
Exelixis, Inc.(NASDAQ:EXEL) volume of the stock was 4.67 million shares in the most recent session and the average volume remained 1.64 million shares. The stock boosted +3.34% and finished the prior session at the closing price of $5.41. The stock traded 4.67 million shares in its previous trading session and its average volume remained 1.64 million shares. Exelixis, Inc., a biotechnology company, engages in developing small molecule therapies for the treatment of cancer in the United States. It focuses on developing and commercializing COMETRIQ (cabozantinib), an inhibitor of multiple receptor tyrosine kinases for the treatment of progressive, metastatic medullary thyroid cancer.
Will EXEL Continue To Move Higher? Find Out Here
Unilife Corp (NASDAQ:UNIS) traded with volume of 4.59 million shares and the average volume of the stock remained 668,034.00 shares. The stock decreased -14.65% and finished the trading at $3.03. The market capitalization of the stock remained 289.59 million. The beta of the stock remained 1.07. Unilife Corporation designs, develops, manufactures, and commercializes injectable drug delivery systems in the United States and internationally. The company?s principal product is the Unifill ready-to-fill syringe, which is designed for pharmaceutical manufacturers in a ready form for filling with their injectable drugs and vaccines.
Will UNIS Get Buyers Even After The Recent Rally? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)